1. Home
  2. TY vs BCRX Comparison

TY vs BCRX Comparison

Compare TY & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tri Continental Corporation

TY

Tri Continental Corporation

HOLD

Current Price

$33.36

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$6.76

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TY
BCRX
Founded
1929
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
TY
BCRX
Price
$33.36
$6.76
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$20.82
AVG Volume (30 Days)
43.0K
4.7M
Earning Date
01-01-0001
02-23-2026
Dividend Yield
3.36%
N/A
EPS Growth
N/A
N/A
EPS
4.78
N/A
Revenue
N/A
$599,816,000.00
Revenue This Year
N/A
$39.83
Revenue Next Year
N/A
$5.47
P/E Ratio
$6.38
N/A
Revenue Growth
N/A
45.38
52 Week Low
$25.16
$6.00
52 Week High
$30.73
$11.31

Technical Indicators

Market Signals
Indicator
TY
BCRX
Relative Strength Index (RSI) 54.76 40.45
Support Level $32.53 $6.46
Resistance Level $33.54 $7.15
Average True Range (ATR) 0.28 0.39
MACD 0.07 -0.05
Stochastic Oscillator 81.68 16.67

Price Performance

Historical Comparison
TY
BCRX

About TY Tri Continental Corporation

Tri-Continental Corp is a United States-based closed-end management investment company. It invests to produce future growth of both capital and income while providing reasonable current income. The fund is divided into two equal segments namely, the equity segment uses quantitative models to select individual stocks whereas the Flexible capital income segment invests across a company's investable capital structure, including stocks, bonds, and convertible securities. The Fund invests in a range of sectors, which include consumer discretionary, consumer staples, energy, financials, healthcare, industrials, information technology, industrials, materials, real estate, telecommunication services, utilities, aerospace and defense, banking, chemicals, and others.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: